Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in 2005 by acquiring CP Medical, Inc., and have continued to expand with the acquisitions of Galt Medical Corp., NeedleTech Products, Inc., Concert Medical, and Arrotek.

List your booth number for exhibitions, ask us

Contact Theragenics and get a quotation

Theragenics is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Gallium Chloride bulk offered by Theragenics

Find a price of Indium Trichloride bulk offered by Theragenics